Technical Analysis for ALT - Altimmune, Inc.

Grade Last Price % Change Price Change
grade D 3.32 14.88% 0.43
ALT closed up 14.88 percent on Tuesday, March 19, 2019, on 12.13 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Earnings due: Mar 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Up
See historical ALT trend table...

Date Alert Name Type % Chg
Mar 19 Crossed Above 50 DMA Bullish 0.00%
Mar 19 MACD Bullish Signal Line Cross Bullish 0.00%
Mar 19 Pocket Pivot Bullish Swing Setup 0.00%
Mar 19 Volume Surge Other 0.00%
Mar 19 Wide Bands Range Expansion 0.00%
Mar 19 Gapped Up Strength 0.00%
Mar 19 Upper Bollinger Band Touch Strength 0.00%
Mar 19 Oversold Stochastic Weakness 0.00%
Mar 18 Crossed Above 20 DMA Bullish 14.88%
Mar 18 Stochastic Buy Signal Bullish 14.88%

Older signals for ALT ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Altimmune,Inc., formerly Pharmathene, Inc., is a biodefense company. The Company is focused on the development of medical counter measures against biological and chemical threats. The Company is involved in the development of two next generation anthrax vaccines. The Company's anthrax vaccines use recombinant protective antigen (rPA) manufacturing processes. The Company's product portfolio includes recombinant butyrylcholinesterase (rBChE) bioscavenger, which is used in prevention and treatment of nerve agent poisoning. The Company has developed a recombinant form of human butyrylcholinesterase for pre- and post-exposure therapy to patients with nerve agent attacks. Its rBChE bioscavenger acts with mechanism, which includes reversal of the acute toxicity associated with organophosphate poisoning agents used in chemical warfare (cholinergic crisis). Its development program also includes Valortim for monoclonal human antibody treatment.
Medicine Medical Specialties Vaccines Anthrax Biological Warfare Manufacturing Processes
Is ALT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 2 bearish and 0 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 49.197
52 Week Low 1.7
Average Volume 1,702,816
200-Day Moving Average 7.1072
50-Day Moving Average 3.0082
20-Day Moving Average 2.9055
10-Day Moving Average 3.049
Average True Range 0.4779
ADX 35.59
+DI 49.4775
-DI 12.008
Chandelier Exit (Long, 3 ATRs ) 4.5063
Chandelier Exit (Short, 3 ATRs ) 3.9637
Upper Bollinger Band 3.7071
Lower Bollinger Band 2.1039
Percent B (%b) 0.76
BandWidth 55.17811
MACD Line -0.0003
MACD Signal Line -0.0156
MACD Histogram 0.0153
Fundamentals Value
Market Cap 51.2 Million
Num Shares 15.4 Million
EPS -1.51
Price-to-Earnings (P/E) Ratio -2.20
Price-to-Sales 7.62
Price-to-Book 0.53
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.55
Resistance 3 (R3) 4.66 4.35 4.35
Resistance 2 (R2) 4.35 4.04 4.30 4.28
Resistance 1 (R1) 3.84 3.85 3.69 3.73 4.21
Pivot Point 3.53 3.53 3.46 3.48 3.53
Support 1 (S1) 3.02 3.22 2.87 2.91 2.43
Support 2 (S2) 2.71 3.03 2.66 2.36
Support 3 (S3) 2.20 2.71 2.30
Support 4 (S4) 2.09